These observations suggest that limitedly-expressed CD47-dependent activation of the CD47–SIRPA signaling in the CRC microenvironment has a significant impact on the clinical outcome of CRC, as similarly observed for other malignancies [13,14]. The gene discussed is CD47; the disease is colorectal carcinoma.